Visiomed Group SA (ALVMG) | Stock Overview & Key Data
Visiomed Group SA | Small-cap | Healthcare
Visiomed Group SA | Small-cap | Healthcare
Visiomed Group SA Performance Comparison
Stock Range
Today's Range
Low: €0.21
High: €0.22
on August 22, 2025
52 Week Range
Low: €0.15
High: €0.25
on December 16, 2024
on September 24, 2024
All-Time High: €173.86 on December 15, 2014
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€53.2M
EPS
0.00
P/E Ratio (TTM)
57.80
Forward P/E
5.75
P/B Ratio
2.10
PEG Ratio
5.75
Div. Yield
N/A
ROE
3.68%
Beta
-0.625
Debt to Equity
32.03
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
6.76%
Profit Margin
6.58%
Returns and Earnings
Return on Assets (TTM)
0.68%
Return on Equity (TTM)
3.68%
EBITDA
€4.2M
Net Income (TTM)
€902.0K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.05
Quarterly Revenue Growth (YoY)
29.30%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Visiomed Group SA ALVMG | 53.17M Small-cap | 5.00% | 16.67% | 16.67% | 0.00% | 23.53% | 23.53% | -48.78% | -80.19% |
| EssilorLuxottica EL | 123.50B Large-cap | 3.38% | 11.70% | 4.45% | -6.50% | 16.14% | 26.57% | 79.07% | 139.75% |
| Sartorius Stedim DIM | 17.27B Large-cap | -0.40% | -7.43% | -11.07% | -13.75% | -4.75% | -0.65% | -53.41% | -40.52% |
| Crossject S.A ALCJ | 85.42M Small-cap | 1.82% | 3.07% | 0.00% | -5.08% | -25.00% | -28.51% | -56.70% | -55.79% |
| Bonyf N.V MLBON | 7.77M Small-cap | 0.00% | 0.00% | -18.35% | -33.51% | -28.33% | -19.38% | 7.50% | 3.20% |
| Spineway S.A ALSPW | 4.61M Small-cap | 0.00% | 8.33% | 8.33% | 0.00% | 44.44% | 8.33% | 8.33% | 8.33% |
Ownership & Short Interest
Insider Ownership
0.00%
Institutional Ownership
2.01%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
500K
Average 90-Day Volume
543K
Visiomed Group SA Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Visiomed Group SA would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALVMG's 52-week high and low?
- In the last 52 weeks, Visiomed Group SA reached a high of €0.25 (on September 24, 2024) and a low of €0.15 (on December 16, 2024).
- What is the market cap and P/E ratio for ALVMG?
- Curious about Visiomed Group SA's size and valuation? Its market capitalization stands at 53.17M. When it comes to valuation, the P/E ratio (trailing twelve months) is 57.80, and the forward P/E (looking ahead) is 5.75.
- Does ALVMG pay dividends? If so, what's the yield?
- As for dividends, Visiomed Group SA isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Visiomed Group SA's main competitors or similar companies to consider before investing?
When looking at Visiomed Group SA, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return EssilorLuxottica
EL123.50B Healthcare Medical Instruments & Supplies 26.57% 79.07% Sartorius Stedim
DIM17.27B Healthcare Medical Instruments & Supplies -0.65% -53.41% Crossject S.A
ALCJ85.42M Healthcare Medical Instruments & Supplies -28.51% -56.70% Bonyf N.V
MLBON7.77M Healthcare Medical Instruments & Supplies -19.38% 7.50% Spineway S.A
ALSPW4.61M Healthcare Medical Instruments & Supplies 8.33% 8.33% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Visiomed Group SA? (e.g., ROE, Debt/Equity)
- To get a sense of Visiomed Group SA's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.68%, the Debt to Equity ratio from the most recent quarter is 32.03, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALVMG?
- Looking at Visiomed Group SA's growth, its revenue over the trailing twelve months (TTM) was €14M. Compared to the same quarter last year (YoY), quarterly revenue grew by 29.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALVMG stock is held by insiders and institutions?
- Wondering who owns Visiomed Group SA stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.01%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.